The biopharmaceutical industry is committed to the discovery and the development of treatments and development of vaccines for infectious diseases, despite their complicated nature. A new report finds that there are 421 medicines and vaccines in clinical development to treat or prevent bacterial and viral infections that cause infectious diseases, including COVID-19.